Pre-Exposure Prophylaxis (PrEP)
PrEP (Pre-Exposure Prophylaxis) is a medication regimen used by HIV-negative individuals to reduce their risk of acquiring HIV. It involves taking a daily pill that contains two antiretroviral drugs, tenofovir disoproxil fumarate and emtricitabine, which work together to prevent HIV from spreading in the body. When taken consistently, PrEP can significantly lower the chances of contracting HIV through sexual activity or injection drug use. It's a highly effective tool in HIV prevention for individuals at high risk of exposure.
Who Should Consider Taking PrEP?
PrEP should be considered by individuals who are HIV-negative but at high risk of contracting HIV.
PrEP is recommended for those who:
Have multiple or HIV-positive partners and engage in condomless sex.
Share injection drug equipment.
Are sexually active gay or bisexual men.
Engage in transactional sex or sex work.
Have had a recent sexually transmitted infection (STI).
Have a partner whose HIV status is unknown or who engages in high-risk behaviors.
Side Effects and Interactions
PrEP drugs may have some side effects such as nausea, diarrhea, headaches, fatigue, abdominal discomfort, dizziness, decreased appetite, and rare changes in bone density or kidney function if they are used for a long time. It is vital for individuals taking PrEP to report any concerns or adverse effects to their healthcare provider to ensure proper management and continued adherence to the medication regimen.